To accelerate your drug discovery campaign, we acquired the state-of-the art device #Dianthus (#NanoTemperTechnologies GmbH), which enables the quantification of molecular interaction by measuring Temperature Related Intensity Change (#TRIC). https://t.co/M1cH9tmrlX
Thursday, Sept 24th join us and @WuXi_AppTec for their fourth episode of “Collaborations That Transform”. This webinar will focus on #MultipleSclerosis drug development challenges, clinical prospects, new therapies & more.
Register now➢ https://t.co/uyV3TyS0gz